HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 31, doi. 10.1007/s00262-011-1087-2
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2012 AND VI 61 AND IP 1
Results: 15
1
2
Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 9, doi. 10.1007/s00262-011-1083-6
- By:
- Publication type:
- Article
3
Immunotherapy with MVA-BN-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 19, doi. 10.1007/s00262-011-1077-4
- By:
- Publication type:
- Article
4
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 41, doi. 10.1007/s00262-011-1089-0
- By:
- Publication type:
- Article
5
Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 49, doi. 10.1007/s00262-011-1090-7
- By:
- Publication type:
- Article
6
CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 63, doi. 10.1007/s00262-011-1092-5
- By:
- Publication type:
- Article
7
Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 71, doi. 10.1007/s00262-011-1085-4
- By:
- Publication type:
- Article
8
Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 79, doi. 10.1007/s00262-011-1078-3
- By:
- Publication type:
- Article
9
Widespread expressions of immunoglobulin superfamily proteins in cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 89, doi. 10.1007/s00262-011-1088-1
- By:
- Publication type:
- Article
10
Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 101, doi. 10.1007/s00262-011-1094-3
- By:
- Publication type:
- Article
11
Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 109, doi. 10.1007/s00262-011-1141-0
- By:
- Publication type:
- Article
12
Ninth annual meeting of the Association for Cancer Immunotherapy (CIMT 2011), May 25-27, 2011, Mainz, Germany.
- Published in:
- 2012
- By:
- Publication type:
- Report
13
A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 119, doi. 10.1007/s00262-011-1160-x
- By:
- Publication type:
- Article
14
Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 1, doi. 10.1007/s00262-011-1151-y
- By:
- Publication type:
- Article
15
Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 127, doi. 10.1007/s00262-011-1173-5
- By:
- Publication type:
- Article